Spend on new drugs expected to drop
The drugs industry expects the NHS to cut its real terms spend on new medicines over the next three years - but it is warning that the slow adoption of new drugs could create avoidable costs.
READ THE ARTICLE
- Get the latest intelligence on NHS policy and agenda
- Learn how healthcare leadership teams are getting it right, who’s getting it wrong and why
- See how innovation is driving quality and efficiency at both local and national level